NFLX is at support, which has held a few times already. Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot. I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.